Effectiveness of chemotherapy using bortezomib combined with homoharringtonine and cytarabine in refractory or relapsed acute myeloid leukemia: a phase II, multicenter, prospective clinical trial

BACKGROUND: Refractory/relapsed acute myeloid leukemia (R/R AML) has unsatisfactory outcomes even after allogeneic hematopoietic stem cell transplantation. Long-term survival is mainly influenced by complete remission (CR) rates after induction therapies. OBJECTIVES: To investigate CR/CR with incomp...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chengtao, Gao, Da, Wang, Xiaohong, Sun, Xiuli, Yan, Yan, Yang, Yan, Zhang, Jingjing, Yan, Jinsong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472935/
https://www.ncbi.nlm.nih.gov/pubmed/37664023
http://dx.doi.org/10.3389/fonc.2023.1142449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472935/
https://www.ncbi.nlm.nih.gov/pubmed/37664023
http://dx.doi.org/10.3389/fonc.2023.1142449

Ejemplares similares